Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Finished Goods (2016 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Finished Goods data on record, last reported at $1.5 billion in Q4 2025.

  • For Q4 2025, Finished Goods rose 15.3% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 15.3%, while the annual FY2025 figure was $1.4 billion, 10.49% up from the prior year.
  • Finished Goods reached $1.5 billion in Q4 2025 per FMS's latest filing, up from $1.3 billion in the prior quarter.
  • Across five years, Finished Goods topped out at $1.5 billion in Q4 2025 and bottomed at $1.3 billion in Q4 2024.
  • Average Finished Goods over 4 years is $1.4 billion, with a median of $1.4 billion recorded in 2021.
  • Peak YoY movement for Finished Goods: decreased 5.19% in 2022, then grew 15.3% in 2025.
  • A 4-year view of Finished Goods shows it stood at $1.4 billion in 2021, then fell by 5.19% to $1.3 billion in 2022, then fell by 5.56% to $1.3 billion in 2024, then increased by 15.3% to $1.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $1.5 billion in Q4 2025, $1.3 billion in Q4 2024, and $1.3 billion in Q4 2022.